156 related articles for article (PubMed ID: 19544475)
1. Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene (Kel).
Zhu X; Rivera A; Golub MS; Peng J; Sha Q; Wu X; Song X; Kumarathasan P; Ho M; Redman CM; Lee S
Am J Hematol; 2009 Aug; 84(8):492-8. PubMed ID: 19544475
[TBL] [Abstract][Full Text] [Related]
2. Giant axon formation in mice lacking Kell, XK, or Kell and XK: animal models of McLeod neuroacanthocytosis syndrome.
Zhu X; Cho ES; Sha Q; Peng J; Oksov Y; Kam SY; Ho M; Walker RH; Lee S
Am J Pathol; 2014 Mar; 184(3):800-7. PubMed ID: 24405768
[TBL] [Abstract][Full Text] [Related]
3. The mouse Kell blood group gene (Kel): cDNA sequence, genomic organization, expression, and enzymatic function.
Lee S; Russo DC; Pu J; Ho M; Redman CM
Immunogenetics; 2000 Nov; 52(1-2):53-62. PubMed ID: 11132157
[TBL] [Abstract][Full Text] [Related]
4. Ablation of the Kell/Xk complex alters erythrocyte divalent cation homeostasis.
Rivera A; Kam SY; Ho M; Romero JR; Lee S
Blood Cells Mol Dis; 2013 Feb; 50(2):80-5. PubMed ID: 23122227
[TBL] [Abstract][Full Text] [Related]
5. The Kell and XK proteins of the Kell blood group are not co-expressed in the central nervous system.
Clapéron A; Hattab C; Armand V; Trottier S; Bertrand O; Ouimet T
Brain Res; 2007 May; 1147():12-24. PubMed ID: 17379193
[TBL] [Abstract][Full Text] [Related]
6. The Kell blood group system: Kell and XK membrane proteins.
Lee S; Russo D; Redman CM
Semin Hematol; 2000 Apr; 37(2):113-21. PubMed ID: 10791880
[TBL] [Abstract][Full Text] [Related]
7. Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.
Ji Y; Veldhuisen B; Ligthart P; Haer-Wigman L; Jongerius J; Boujnan M; Ait Soussan A; Luo G; Fu Y; van der Schoot CE; de Haas M
Transfusion; 2015 Feb; 55(2):413-21. PubMed ID: 25156717
[TBL] [Abstract][Full Text] [Related]
8. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells.
Daniels GL; Weinauer F; Stone C; Ho M; Green CA; Jahn-Jochem H; Offner R; Monaco AP
Blood; 1996 Nov; 88(10):4045-50. PubMed ID: 8916972
[TBL] [Abstract][Full Text] [Related]
9. Expression profiles of mouse Kell, XK, and XPLAC mRNA.
Lee S; Sha Q; Wu X; Calenda G; Peng J
J Histochem Cytochem; 2007 Apr; 55(4):365-74. PubMed ID: 17189525
[TBL] [Abstract][Full Text] [Related]
10. Kell, Kx and the McLeod syndrome.
Redman CM; Russo D; Lee S
Baillieres Best Pract Res Clin Haematol; 1999 Dec; 12(4):621-35. PubMed ID: 10895256
[TBL] [Abstract][Full Text] [Related]
11. Onset of expression of the components of the Kell blood group complex.
Pu JJ; Redman CM; Visser JW; Lee S
Transfusion; 2005 Jun; 45(6):969-74. PubMed ID: 15934996
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-3-converting enzyme activity of the KEL1 and KEL6 phenotypes of the Kell blood group system.
Sha Q; Redman CM; Lee S
J Biol Chem; 2006 Mar; 281(11):7180-2. PubMed ID: 16423827
[TBL] [Abstract][Full Text] [Related]
13. Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice.
Escamilla-Rivera V; Liu J; Gibb DR; Santhanakrishnan M; Liu D; Forsmo JE; Eisenbarth SC; Foxman EF; Stowell SR; Luckey CJ; Zimring JC; Hudson KE; Hendrickson JE
Blood; 2020 May; 135(22):1983-1993. PubMed ID: 32266378
[TBL] [Abstract][Full Text] [Related]
14. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
[TBL] [Abstract][Full Text] [Related]
15. Functional and structural aspects of the Kell blood group system.
Lee S; Russo D; Redman C
Transfus Med Rev; 2000 Apr; 14(2):93-103. PubMed ID: 10782495
[TBL] [Abstract][Full Text] [Related]
16. Kell and Kx blood group systems.
Denomme GA
Immunohematology; 2015; 31(1):14-9. PubMed ID: 26308465
[TBL] [Abstract][Full Text] [Related]
17. Kell and XK immunohistochemistry in McLeod myopathy.
Jung HH; Russo D; Redman C; Brandner S
Muscle Nerve; 2001 Oct; 24(10):1346-51. PubMed ID: 11562915
[TBL] [Abstract][Full Text] [Related]
18. Identification of a defect in the intracellular trafficking of a Kell blood group variant.
Yazdanbakhsh K; Lee S; Yu Q; Reid ME
Blood; 1999 Jul; 94(1):310-8. PubMed ID: 10381527
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens.
Yu LC; Twu YC; Chang CY; Lin M
J Biol Chem; 2001 Mar; 276(13):10247-52. PubMed ID: 11134029
[TBL] [Abstract][Full Text] [Related]
20. Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.
Lomas-Francis C; Vege S; Velliquette RW; Fuchisawa A; Uchikawa M; Tani Y; Moro H; Debnath AK; Westhoff CM
Transfusion; 2013 Nov; 53(11 Suppl 2):2887-91. PubMed ID: 23968329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
